I wrote on May 29 about my worry regarding a dry, flaky patch of skin on my nose. Unsure of the status of this unusual spot, I immediately called my dermatologist and made an appointment -- which did not end up being all that immediate. The earliest slot available for addressing my personal crisis was June 12 at 11 AM. I took it. And then the stars aligned and I got a call on this very same day.

"We have a cancellation tomorrow. Do you want to come in then?" said the voice on the other end of the phone. Yes, yes, yes, I wanted it. And so I took this slot instead.

Yesterday I met with my dermatologist. The good news is: what I found on the bridge of my nose is not cancer. The bad news is: it was trying really hard to become cancer.

Sad news for the female cancer survivors out there with decreased libido. Topical testosterone creams do not seem to work. A decrease in libido is a common problem among female cancer survivors.

When is our Viagra going to come out?

Seriously though, its tough being in a position where chemotherapy wrecks havoc on our bodies and ruins our libido -- then we are told there is nothing we can do about it. I'm a breast cancer survivor with estrogen positive disease so it is not recommended that I use any supplemental estrogen.

Testosterone cream was tried out in a study, published in the Journal of the National Cancer Institute, that included 150 post-menopausal breast cancer survivors. Half received the testosterone cream and the other half a placebo. The study found that there was no statistical difference in libido between the testosterone cream and placebo groups.

However, all women in the study did show some increase in sexual desire. What that means is that just thinking it might work made some women more horny -- this is known as the placebo effect.

While the effectiveness of a seaweed extract acting as a potent inhibitor of human papilloma viruses, HPV, that can lead in some cases to cervical cancer, has not been tested in any human clinical trials -- in the lab it has impressed the National Cancer Institute researchers who have been studying it.

According to researchers, carrageenan extracted from marine red algae (seaweed) showed a thousand-fold greater potency compared with other inhibitors they have tested in halting HPV.

Dr. John Schiller, senior investigator at the National Cancer Institute, who was involved in the development of the HPV vaccine, made the carrageenan discovery.

Schiller cautions that the results do not prove that carrageenan will work as a practical HPV topical microbicide. However, the positive results in the lab, together with the fact that carrageenan-based over-the-counter products are already available -- make carrageenan look even more promising to researchers in blocking the sexual transmission of HPV.

The new cervical cancer vaccine is effective for about 70 percent of the HPV viruses that can cause cervical cancer. It is also an expensive vaccine that might prove cost prohibitive for low-income women in economically distressed countries. The researchers think, if carrageenan proves as effective in human clinical trails as it has in the lab, the inexpensive carrageenan could be a significant benefit in the prevention of HPV.

One researcher, Dr. Connie Trimble, an HPV researcher at Johns Hopkins University, feels so positive about the recent advancements and discoveries in relation to cervical cancer that she said, "With all the potential tools now, we could really start to think about the end of cervical cancer. Between the vaccines and some of the prophylactics -- wouldn't that be a medical success story!"